BSX | Trendline Broken, Order Block Held — One Level LeftBoston Scientific CorporationBATS:BSXBigBelugaBy analyzing the #BSX (Boston Scientific) chart on the 4H timeframe, we can see a market that has spent the year being sold and has just spent two months doing something different. The downtrend is structurally broken, demand has been tested and held, and the whole setup now rests on one level. 4H Timeframe The context first, because it explains why this matters. From April onward, BSX was in a clean bearish sequence — four consecutive BOS to the downside, each low taken out in turn, the entire move contained inside a descending trendline that capped every attempt to recover. That is a market where sellers set the terms for months without ever losing them. That ended in late July. Price printed a bullish MSS and broke through the descending trendline in the same move. Two things at once: the sequence of lower highs was interrupted, and the structure that had been containing the decline was gone. What followed is the part that matters more than the break itself. Price rallied to $52.50, then retraced all the way back into the Order Block at $44.90 – $46.10 — the origin of the move that broke the trendline. It held. The reaction from that block was immediate and clean, and price is now trading around $47.81, back above it. A break is one thing. A break that gets retested and defended is another. This is the second one. Above, the level that decides everything: $49.75. That is the high of the retracement and the last structural obstacle between current price and open space. Beyond it, two pools of liquidity rest untouched — $58.67 and $66.81 — neither of which has been revisited since the decline began. Beneath everything, the Protected Low at $42.23 holds the entire premise together. The Bias Bullish while price holds above the Protected Low. The trigger is specific and the invalidation is specific. Scenario A — the base case. A decisive close above $49.75 confirms the reversal and opens the path directly to the resting liquidity. That level has capped price since the retracement began, and clearing it means the market has run out of structural reasons to stay in this range. From there the objectives are $58.67 first, then $66.81. Both are untouched, and there is very little structure between $49.75 and $58.67 — the decline through that region was fast, which means the way back up can be too. The reasoning is straightforward. The trendline is broken, the MSS is in, the Order Block was tested and defended without a single close beneath it. Every structural condition has been met except the last one. Scenario B — one more retest. Price may return into the Order Block at $44.90 – $46.10 a second time before committing. That is not a failure — a zone that held once and holds again is a stronger zone, not a weaker one. A reaction there is the same trade at a better price, with risk defined just beneath the Protected Low. What is not the trade: buying here, mid-range, beneath an unbroken level. The $49.75 close is what converts this from a possibility into a position. Invalidation. A decisive close beneath the Protected Low at $42.23 ends the bullish case entirely. Below that level the MSS was a failed break, the Order Block gave way, and the downtrend that produced four consecutive BOS was never actually interrupted. And the rule that governs all of it: a break is a candle close, not a wick. $49.75 is exactly the kind of level that gets spiked through intraday and rejected by the close. Fundamental Backdrop This is where the chart and the news are pointing in opposite directions, and that tension is the whole story here. The damage is real and recent. On 26 August, BSX disclosed a cybersecurity incident and dropped 6% in a session. The attack disrupted operations and forced global product recalls. The company subsequently lowered its 2026 sales and earnings guidance. The stock is down roughly 49.6% year to date and around 55% from its all-time closing high of $108.14 set in September 2025 — almost exactly a year ago. The recovery signals are also real. TD Cowen described the shipping restoration update as a significant step forward, and the company has begun restoring shipping for the majority of products at its major distribution facility. Analyst consensus across 22 analysts remains Buy, with a price target of $71.91 — more than 50% above current price. Call volume was flagged as above normal and directionally bullish in late August, and an insider made a notable share purchase on 26 August, the same week the stock fell. The setup underneath is a company with a diversified portfolio in cardiovascular and MedSurg trading at a P/E of 19.38 after losing half its value on an operational disruption rather than a structural decline in its business. Whether that disruption is temporary is the question the market is currently pricing. What matters here is that the chart made its move before the news improved. The trendline broke in late July, weeks before the cyberattack, and the Order Block held through it. That is a structure absorbing bad news rather than breaking on it — which is usually a more meaningful signal than the news itself. This analysis will be updated as the market evolves. Best Regards, BigBeluga 🐳